Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioptik Technology is a Taiwan-based publicly traded healthcare company focused on commercial-stage medical devices, rapid diagnostic products, health supplements, and related OEM/ODM manufacturing. The company is best known for at-home and professional monitoring systems for blood glucose and other analytes, including cholesterol, uric acid, hemoglobin, triglycerides, and ketones, sold under brands such as EasyTouch, EasyMate, EasySure, and PeTouch. Beyond human diagnostics, it has expanded into pet healthcare products and home rapid test kits, and it also manufactures dietary supplements, skincare, and wound-care related products. Bioptik appears to operate primarily as a diagnostics and health products manufacturer rather than a therapeutics developer, with meaningful in-house manufacturing and an international export footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioptik Technology.